Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles
Authors
Keywords
Hederagenin, P-glycoprotein, Nitrogen-containing heterocycle, Drug resistance reversal activity, Synthesis
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages 114207
Publisher
Elsevier BV
Online
2022-02-19
DOI
10.1016/j.ejmech.2022.114207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: synthesis and clinical application
- (2021) Shuai Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Jatrophane diterpenoids as multidrug resistance modulators from Euphorbia sororia
- (2021) Hequn Yang et al. BIOORGANIC CHEMISTRY
- Pyxinol bearing amino acid residues: Easily achievable and promising modulators of P-glycoprotein-mediated multidrug resistance
- (2021) Conghui Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- VE-822, a novel DNA Holliday junction stabilizer, inhibits homologous recombination repair and triggers DNA damage response in osteogenic sarcomas
- (2021) Qikun Yin et al. BIOCHEMICAL PHARMACOLOGY
- Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: A review
- (2021) Arif Mermer et al. BIOORGANIC CHEMISTRY
- Structure-activity relationship and mechanism of flavonoids on the inhibitory activity of P-glycoprotein (P-gp)-mediated transport of rhodamine123 and daunorubicin in P-gp overexpressed human mouth epidermal carcinoma (KB/MDR) cells
- (2021) Yajing Fang et al. FOOD AND CHEMICAL TOXICOLOGY
- The protective effect of Hederagenin on pulmonary fibrosis by regulating the Ras/JNK/NFAT4 axis in rats
- (2020) Wenjing Ma et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin
- (2020) Marina Sagnou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
- (2020) Hang Zhang et al. MEDICINAL RESEARCH REVIEWS
- Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer
- (2020) Ricardo J. Ferreira et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity
- (2020) Binghua Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Piperazine-azole-fluoroquinolone hybrids: Conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies
- (2019) Arif Mermer et al. BIOORGANIC CHEMISTRY
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Advances in the relationship between glycosyltransferases and multidrug resistance in cancer
- (2019) Yinshuang Wu et al. CLINICA CHIMICA ACTA
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Natural products as multidrug resistance modulators in cancer
- (2019) Amit Kumar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo
- (2019) Fangfang Li et al. Acta Pharmaceutica Sinica B
- Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance
- (2019) Mengqi Guo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ingol diterpenoids as P-glycoprotein-dependent multidrug resistance (MDR) reversal agents from Euphorbia marginata
- (2019) Yao Zhang et al. BIOORGANIC CHEMISTRY
- H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo
- (2018) Yanting Yang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review
- (2018) Jia Zeng et al. RSC Advances
- A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth
- (2018) Di Zhang et al. International Journal of Nanomedicine
- Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers
- (2018) Ricardo J. Ferreira et al. JOURNAL OF NATURAL PRODUCTS
- Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells
- (2018) Iva Guberović et al. Scientific Reports
- Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance
- (2018) Qianwen Ren et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents
- (2018) Xiao Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, synthesis of novel fusidic acid derivatives possessed amino-terminal groups at the 3-hydroxyl position with anticancer activity
- (2018) Jingxuan Ni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity
- (2017) Xian-xuan Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities
- (2017) Jawaid Akhtar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
- (2017) Prashant Joshi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells
- (2017) Angela Paterna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
- (2017) Piyush Bugde et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Triterpenoids from Momordica balsamina : Reversal of ABCB1-mediated multidrug resistance
- (2016) Cátia Ramalhete et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Copper-Catalyzed Domino Synthesis of Nitrogen Heterocycle-Fused Benzoimidazole and 1,2,4-Benzothiadiazine 1,1-Dioxide Derivatives
- (2015) Daoshan Yang et al. ACS Combinatorial Science
- Triterpenoids as reversal agents for anticancer drug resistance treatment
- (2013) Xiao-Jian Yan et al. DRUG DISCOVERY TODAY
- Synthesis and Biological Evaluation of Heterocyclic Ring-Fused Betulinic Acid Derivatives as Novel Inhibitors of Osteoclast Differentiation and Bone Resorption
- (2012) Jun Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started